Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet-Induced Obese Mice
Diabetes (New York, N.Y.), 2020-06, Vol.69 (6), p.1292-1305 [Peer Reviewed Journal]2020 by the American Diabetes Association. ;Copyright American Diabetes Association Jun 1, 2020 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/db19-0991 ;PMID: 32234722
Full text available